作者: Ke Zeng , Haijin Li , Chenyu Zhang , Yi Ba , Junfeng Zhang
DOI:
关键词: Biochip 、 Cancer research 、 Lung cancer 、 Reagent 、 RNA 、 Non small cell 、 Recurrence prediction 、 Differential diagnosis 、 Medicine 、 Small RNA
摘要: The present invention provides a combination of tiny ribonucleic acid (RNA) for estimating the status non-small cell lung cancer, including 26 kinds stabilized existing and detectable small RNA in serum/plasma subjects. A method cancer subjects includes determination kit tool biochip components can be used diagnosis differential diagnosis, disease complications occurrence recurrence prediction, efficacy evaluation, as well screening drugs active ingredients, like fields.